Feature|HRS|May 20, 2020

Heart Rhythm Society 2020 Late-Breaking Clinical Trials in Electrophysiology

The latest science in EP to treat cardiac arrythmias

HRS 2020 Late-Breaking Clinical Trials in Electrophyiology

May 20, 2020 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them from the心律社会(HRS)2020 virtual meeting. The in-person meeting was cancelled this year because of the continuing COVID-19 containment efforts. The presentations are divided into four LBCT sessions, which are all available on demand on Heart Rhythm 365 available atwww.hrsonline.org/HRS2020Sciencestarting on Friday, May 8, 2020, as well as in theHeart Rhythm Journal May Issue Supplement

Friday, May 8, 2020

HRS Late-Breaking Clinical Trials -Randomized Trials

Etripamil Nasal Spray For Acute Termination Of Spontaneous Episodes Of Paroxysmal Supraventricular Tachycardia (Node-301 Trial)。Bruce S. Stambler. M.D., FHRS, Piedmont Heart Institute, Atlanta, Ga.

A Randomized Trial Of Subcutaneous Versus Transvenous Defibrillator Therapy: The PRAETORIAN Trial.Reinoud Knops, M.D. Ph.D., Academic Medical Center, Hilversum, Netherlands

Convergence Of Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Persistent AFDavid De Lugio, M.D., FHRS, Emory Saint Joseph`s Hospital, Atlanta, Ga.

Persistent Atrial Fibrillation Ablation With a Contact Force Sensing Catheter: The Prospective Multicenter PRECEPT Trial with the Thermocool Smarttouch SF Catheter.Moussa Mansour, M.D., FHRS, Massachusetts General Hospital, Boston, Mass.

Smart Watches Significantly Improve Adherence To Oral Anticoagulation Therapy Among Patients With Atrial FibrillationZhan Shi,M.D.,北京朝阳医院,北京市北京市

HRS Late-Breaking Clinical Trials -Innovation Boulevard

Left Bundle Branch Pacing As A Novel Strategy For Cardiac Resynchronization Therapy: Results From International LBBP Collaborative Study Group.Pugazhendhi Vijayaraman, M.D., FHRS, Geisinger Heart Institute, Mountain Top, Penn.

Longer Term Results From A Phase I/II Study Of EP-guided Noninvasive Cardiac Radioablation For Treatment Of Ventricular Tachycardia (ENCORE-VT)Philip Cuculich, M.D., Washington University, St. Louis, Mo.

视频:心脏放射疗法消融治疗心室心动过速— Interview with Clifford Robinson, M.D.

Pulsed AF: First Human Experience And Acute Procedural Outcomes Using A Novel Pulsed Field Ablation System。Atul Verma, M.D., FHRS, Southlake Regional Health Center, Toronto, Onterio, Canada

Point-by-point Pulsed Field Ablation (+/- Radiofrequency Ablation) To Treat Atrial Fibrillation: A First-in-human Trial.Vivek Y. reddy,M.D.,Icahn Sinai山,纽约,N.Y。

Understanding Outcomes With The S-ICD In Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial Primary Results.Michael R. Gold, M.D., Ph.D., FHRS, Medical University of South Carolina, Charleston, S.C.

Saturday May 9, 2020

HRS Late-Breaking Clinical Trials - All About AFib

通过消融指数技术改善食管保护期间:影响研究的结果Mark M. Gallagher, M.D., St George's Hospital Medical School, London, U.K.

Incidence Of Silent Brain Infarcts In Anticoagulated Patients With Atrial Fibrillation in Swiss-AF StudyDavid Conen,M.D.,MPH,MPH,McMaster大学,加拿大安大略省汉密尔顿

Primary Outcome Evaluation Of A Next Generation Left Atrial Appendage Closure Device: The PINNACLE FLX Trial.Shephal K Doshi, M.D., Pacific Heart Institute, Santa Monica, Calif.

Atrial Fibrosis Predicts Recurrent Stroke Or New Atrial Fibrillation In Patients With Embolic Stroke Of Undetermined Source - A Multi-Center Study.Nazem Akoum, M.D., MS, FHRS, University of Washington, Seattle, Wash.

活性细胞外基质重塑准备未来心房颤动的心脏。预测-AF试验的第一个结果。尤里斯。r . de Groot,医学博士,博士,阿姆斯特丹UMC, Amsterdam, Netherlands

HRS Late-Breaking Clinical Trials - This Could Change My Practice

Comparison Of Outcomes Among Patients Implanted With A Tined, Leadless Versus Transvenous Single-chamber Ventricular Pacemaker In The Novel Micra Coverage With Evidence Development Study.Jonathan P. Piccini, M.D., MHS, FHRS, Duke University Medical Center, Durham, N.C.

Predicted Benefit Of The Implantable Cardioverter Defibrillator: The MADIT-ICD Benefit ScoreArwa Younis, M.D., University of Rochester Medical Center, Rochester, N.Y.

Assessment Of Absolute Risk Of Life-threatening Cardiac Events In Long QT Syndrome Patients.Wojciech Zareba, M.D., Ph.D., University of Rochester Center, Rochester, N.Y.

Ablation Of Refractory Ventricular Tachycardia With A Heated-saline Needle Catheter For Enhanced Radiofrequency (SERF) Ablation With Creation Of Transmural Lesions: A First-in-man Feasibility Study.Douglas L Packer, M.D., FHRS, Mayo Clinic-St. Mary`s Hospital, Rochester, Minn.

Performance Of First In The World Pacemaker To Use Smart Device App For Remote MonitoringKhaldoun G. Tarakji, M.D., MPH, FHRS, Cleveland Clinic, Cleveland, Ohio

Other Heart Rhythm 2020 News:

视频:心脏放射疗法消融治疗心室心动过速— Interview with Clifford Robinson, M.D.

FDA Clears HeartLight X3 Laser Ablation System to Treat Atrial Fibrillation

VIDEO: Top New EP Technologies at Heart Rhythm Society 2020— Interview with Andrew Krahn, M.D.

FDA Approves Medtronic Cobalt and Crome ICD Portfolio

视频:洞察HRS如何组织其虚拟会议— Interview with Andrew Krahn, M.D.

Related Recent Late-breaking Cardiology Trial Presentations:

Heart Rhythm Society 2019 Late-Breaking Clinical Trials

ACC 2020 Late-breaking Presentations

TCT.2019 Late-breaking Presentations

2019年美国心脏协会最新的恐怖主义风险保险法案ls

Related Content

The SERF VT EFS is a groundbreaking, single-arm observational study designed to evaluate the safety and effectiveness of the Thermedical Durablate catheter to treat VT. #HRS20 #HRS2020 #heartrhythm2020
News|消融系统|May 08, 2020
May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SER
The Affera Inc. pulsed field (PF) energy radiofrequency ablation system. First-in-human trial shows new point-by-point approach provides increased flexibility and efficiency for physicians treating arrhythmia patients. #HRS #HRS2020 #HRS20 #heartrhythm20

The Affera Inc. pulsed field (PF) energy radiofrequency ablation system.

Feature|消融系统|May 08, 2020
May 8, 2020 — A new clinical trial effectively uses pulsed field (PF) energy to treat patients with persistent or par
Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News|消融系统|September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically
Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News|消融系统|May 16, 2019
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter...
CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News|消融系统|May 16, 2019
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3...
New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias
News|消融系统|May 14, 2019
The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an international consensus...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News|消融系统|May 13, 2019
原型宣布与荷兰海牙HAGA医院签署了商业协议,以装备......
一种纤维心脏消融放射治疗的治疗计划,显示辐射束将消融非侵入性肺静脉隔离程序。Varian收购,购买Cyber​​heart。

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature|消融系统|May 10, 2019| Dave Fornell, Editor
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
Ablation Reduces Risk of Dementia in Patients With AFib and Carotid Artery Disease
News|消融系统|May 08, 2019
Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new research finds it...